Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference24 articles.
1. Yamashita K, Kaneko M, Narukawa M. A significant anticancer drug approval lag between Japan and the United States still exists for minor cancers. Clin Pharmacol Ther. 2019;105:153–60.
2. Tsuji K, Tsutani K. If Japan is to become a front-runner in pharmaceutical development. Nature. 2008;32:851–2.
3. Ministry of Health, Labour and Welfare. Basic principles on Global Clinical Trials (Notification No.0928010 of Evaluating and Licensing Division, Pharmaceutical and Food Safety Bureau dated September 28, 2007) https://www.pmda.go.jp/files/000153265.pdf. Accessed June 3, 2020.
4. Kondo H, Shimada Y, Ozawa T. Promotion of Japan's participation in global clinical trials. Drug Discov Today. 2019;24:939–42.
5. Miyazaki K, Sato Y, Hanaoka H, Uyama Y. Current status and open issues concerning global clinical trials (GCTs) in Japan and East Asia. Clin Transl Sci. 2017;10:503–8.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献